We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

Anthony S. Stein,

Hematologist-Oncologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Specialties
Hematologic Oncology
Education
Medical school:
Degrees

  • 1978, University of Cape Town Medical School, Cape Town, South Africa, M.B., Ch, B.

Fellowship

  • 1985-1988, Fellowship, City of Hope, Duarte, CA, Hematology/Oncology

Residency

  • 1982-1985, Residency, Department of Medicine, Internal Medicine, Montefiore Hospital, Pittsburgh, PA

Internship

  • 1979, Internship (Rotating), Groote Schuur Hospital, Cape Town, South Africa

Professional Experience

  • 2016-present, Associate Director, Gehr Family Center for Leukemia Research, Hematologic Malignancies Research Institute, City of Hope, Duarte, CA

  • 1988-present, Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Academic Appointments
  • Associate Director, Gehr Family Center for Leukemia Research
  • Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
About Me
“Excellent care for patients” is the guiding principle for Anthony S. Stein, M.D., a member of the City of Hope team since 1985. Dr. Stein is a professor and physician in the Department of Hematology & Hematopoietic Cell Transplantation and associate director of the Gehr Family Center for Leukemia Research within the Hematologic Malignancies Research Institute.
 
Educated in South Africa, Dr. Stein received his medical degree from the University of Cape Town. He completed his residency at Montefiore Medical Center in Pittsburgh before joining City of Hope as a fellow in hematology/oncology.
 
Dr. Stein is principal investigator in multiple clinical trials examining the newest drugs for battling acute myeloid leukemia and acute lymphoid leukemia and hematopoietic stem cell transplantation.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.